Literature DB >> 26716064

Reversible long-standing severe disability in idiopathic normal pressure hydrocephalus.

Ayman M Selim1, Colleen Ray1, Michael D Cusimano1, Eloise Karp1, Morris Freedman1.   

Abstract

Entities:  

Year:  2015        PMID： 26716064      PMCID： PMC4684672          DOI： 10.1212/CPJ.0000000000000149

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN： 2163-0402


× No keyword cloud information.
  7 in total

1.  SYMPTOMATIC OCCULT HYDROCEPHALUS WITH "NORMAL" CEREBROSPINAL-FLUID PRESSURE.A TREATABLE SYNDROME.

Authors:  R D ADAMS; C M FISHER; S HAKIM; R G OJEMANN; W H SWEET
Journal:  N Engl J Med       Date:  1965-07-15       Impact factor: 91.245

2.  The behavioural neurology assessment.

Authors:  S Darvesh; L Leach; S E Black; E Kaplan; M Freedman
Journal:  Can J Neurol Sci       Date:  2005-05       Impact factor: 2.104

3.  Good outcome in patients with normal-pressure hydrocephalus and factors indicating poor prognosis.

Authors:  Maria A Poca; Maria Mataró; Mar Matarín; Fuat Arikan; Carme Junqué; Juan Sahuquillo
Journal:  J Neurosurg       Date:  2005-09       Impact factor: 5.115

Review 4.  Idiopathic normal pressure hydrocephalus: a systematic review of diagnosis and outcome.

Authors:  A O Hebb; M D Cusimano
Journal:  Neurosurgery       Date:  2001-11       Impact factor: 4.654

5.  Normal pressure hydrocephalus presenting as mania.

Authors:  J A Kwentus; R P Hart
Journal:  J Nerv Ment Dis       Date:  1987-08       Impact factor: 2.254

6.  Meningeal cryptococcosis misdiagnosed as a manic episode.

Authors:  O J Thienhaus; N Khosla
Journal:  Am J Psychiatry       Date:  1984-11       Impact factor: 18.112

7.  Guidelines for management of idiopathic normal pressure hydrocephalus: second edition.

Authors:  Etsuro Mori; Masatsune Ishikawa; Takeo Kato; Hiroaki Kazui; Hiroji Miyake; Masakazu Miyajima; Madoka Nakajima; Masaaki Hashimoto; Nagato Kuriyama; Takahiko Tokuda; Kazunari Ishii; Mitsunobu Kaijima; Yoshihumi Hirata; Makoto Saito; Hajime Arai
Journal:  Neurol Med Chir (Tokyo)       Date:  2012       Impact factor: 1.742
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.